Details

Category:

Other publications

Type:

Other publications

Title of issue:

Journal of Geriatric Care and Research. 2017, Vol 4, No 2

Publication year:

2017

Bibliography: test

1. Faurbye A, Rasch RJ, Bender Peterson P, et al. Neurological symptoms in pharmacotherapy of psychosis. Acta Psychiatr Scand 1964; 40: 10-27. open in new tab
2. Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 2004 open in new tab
3. Seeman P. Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizophr Relat Psychoses 2010; 4:56- 73. open in new tab
4. Smith JM, Baldessarini RJ. Changes in prevalence, severity and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980; 37:1368-1373. open in new tab
5. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord 2006; 21:589-598. open in new tab
6. Bhidayasiri R, Boonyawairoj S. Spectrum of tardive syndromes: clinical recognition and management. Postgrad Med J 2011; 87:132-141. open in new tab
7. Hugenholtz GW, Heerdink ER, Stolker JJ, et al. Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses. J Clin Psychiatry 2006; 67:897-903. open in new tab
8. Rosenheck R, Stroup S, Keefe RS, et al. Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 2005; 187:529-536. open in new tab
9. Connor DF, Fletcher KE, Wood JS. Neuroleptic-related dyskinesias in children and adolescents. J Clin Psychiatry. 2001 Dec. 62(12):967-74. open in new tab
10. Go CL, Rosales RL, Caraos RJ, et al. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Parkinsonism Relat Disord. 2009 Nov. 15(9):655-9. open in new tab
11. Kulkarni SK, Naidu PS. Pathophysiology and drug therapy of TD: current concepts and future perspectives. Drugs Today (barc) 2003;39(1):19-49. open in new tab
12. Margolese HC, Chouinard G, Kolivakis TT, et al. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: incidence and management strategies in patient with schizophrenia. Can J Psychiatry 2005;50:703-14. open in new tab
13. Kapur S, Seeman P. Does fast dissociation from the dopamine d (2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 2001;158:360-9. open in new tab
14. Gerlach J, Reisby N, Randrup A. Dopaminergic hypersensitivity and cholinergic hypo function in the pathophysiology of tardive dyskinesia. Psychopharm 1974;34:21-35. open in new tab
15. Soares KV, McGrath JJ, Deeks JJ. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia. Cochrane Database Sys Rev 2000(2). open in new tab
16. Weiner WJ, Lang AE. Movement Disorders: A Comprehensive Survey. Mount Kisco, N.Y.: Futura Publishing Company 1989; 600-602.
17. Huttunen M. The evolution of the serotinine-dopamine antagonist concept. J Clin Pschopharmacol 1995; 15: 4-10. open in new tab
18. Lieberman J.A., Saltz B.L., Johns C.A., et al. The effects of clozapine on tardive dyskinesia. Br. J. Psychiatry 1991;158, 503-510. open in new tab
19. Dalac G.W., Becks L., Meador-Woodruff J. H. Tardive dyskinesia, clozapine and treatment response. Prg. Neuro- Psychopharmacol. Biol. Psychiatry 1998;22, 256-573. open in new tab
20. Bassitt DP, Louza Neto MR: Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 1998; 209-211. open in new tab
21. De LEON L, Moral L, Camunas C. Clozapine and jaw dyskinesia: a case report. J. Clin. Psychiatry 1991;52, 494- 495.
22. Gafoor R, Brophy J. Three case reports of emergent dyskinesia with clozapine. Eur Psychiatry 2003;18. 260-261. open in new tab
23. Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist 2003; 9:16-27. open in new tab
24. Lane RD, Glazer WM, Hansen TE, et al. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis 1985; 173(6):353-7. open in new tab
25. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharacol Ther 1981; 30: 239-45 open in new tab
26. Ertugrul A, Demir B. Clozapine-induced tardive dyskinesia: A case report. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:633-5. open in new tab
27. Kane JM, Woerner MG, pollack S et al. Does clozapine cause Tardive Dyskinesia? J Clin Psychiatry 1993; 54:327-30. open in new tab
28. Kane J.M. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J. Clin. Psychiatry 2004; 65.

show (28) hide

Verified by:

No verification